Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Allogene Therapeutics, Inc. | 95,400 | reported | 18 Jun 2025 | tx 6+492,417−10,000 |
| Merck & Co., Inc. | 12,539.83 | reported | 30 May 2025 | tx 6+11,715.1 |
| Sarepta Therapeutics, Inc. | 1,765 | reported | 12 Mar 2026 | tx 13+38,040−11,232 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | SALE | Sarepta Therapeutics, Inc. | 7,239 | 17.02 USD | |
| 18 Jun 2025 | GRANT_AWARD | Allogene Therapeutics, Inc. | 95,400 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Merck & Co., Inc. | 2,863.09 | 76.84 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 2,383 | — | |
| 10 Mar 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 4,792 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Allogene Therapeutics, Inc. | 191,082 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | Merck & Co., Inc. | 1,752.43 | 125.54 USD | deriv |
| 05 Mar 2024 | SALE | Sarepta Therapeutics, Inc. | 3,135 | 122.96 USD | |
| 01 Mar 2024 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 1,846 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 3,679 | 0.00 USD | deriv |
| 07 Aug 2023 | SALE | Allogene Therapeutics, Inc. | 10,000 | 4.29 USD | |
| 13 Jun 2023 | GRANT_AWARD | Allogene Therapeutics, Inc. | 116,120 | 0.00 USD | deriv |
| 26 May 2023 | GRANT_AWARD | Merck & Co., Inc. | 1,980.73 | 111.07 USD | deriv |
| 06 Mar 2023 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 1,523 | 0.00 USD | |
| 06 Mar 2023 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 3,257 | 0.00 USD | deriv |
| 17 Nov 2022 | SALE | Sarepta Therapeutics, Inc. | 858 | 109.92 USD | |
| 08 Jul 2022 | GRANT_AWARD | Allogene Therapeutics, Inc. | 35,328 | 0.00 USD | |
| 08 Jul 2022 | GRANT_AWARD | Allogene Therapeutics, Inc. | 54,487 | 0.00 USD | deriv |
| 27 May 2022 | GRANT_AWARD | Merck & Co., Inc. | 2,363.56 | 93.08 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 2,953 | 0.00 USD | |
| 07 Mar 2022 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 5,077 | 0.00 USD | deriv |
| 16 Nov 2021 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 4,292 | 0.00 USD | |
| 16 Nov 2021 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 8,238 | 0.00 USD | deriv |
| 28 May 2021 | GRANT_AWARD | Merck & Co., Inc. | 2,635.39 | 75.89 USD | deriv |
| 15 Mar 2021 | GRANT_AWARD | Merck & Co., Inc. | 119.9 | 76.23 USD | deriv |